Home » Topics » Regulatory

Regulatory
RSS

Roche seeks FDA approval for Xenical as adjunct in type 2 diabetes

March 23, 2001

Two new antiglaucoma drugs approved by FDA

March 19, 2001

Abbott and NaPro BioTherapeutics file ANDA for paclitaxel

March 19, 2001

New doses of Kadian approved in U.S.

March 15, 2001

Roche seeks FDA approval for Xeloda/Taxotere combination for the treatment of breast cancer

March 9, 2001

FDA approves multidose formulation of Serono's Gonal-F for ovarian stimulation

March 7, 2001

Faulding to market and sell NaPro's paclitaxel in Europe

March 5, 2001

CPMP issues positive opinion for new NeoRecormon indication

March 5, 2001

Early March launch for new antiallergic agent from Kyowa Hakko

Feb. 27, 2001

Iomed enrolls over 300 patients in phase III study for epicondylitis

Feb. 26, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...